GlassScriptPhysician profile
Katherine Rose
NPI 1548903255
$2,677.08
in general payments reported to CMS, 2019-2025
19 companies · $931 in 2025
The $931 reported for 2025 was more than what 79% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $266 · 2023: $420 · 2024: $1,060 · 2025: $931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,411.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $506.44 | 2023-2024 | Zoryve |
| Incyte Corporation | $323.45 | 2022-2025 | Opzelura, Opzelura |
| Amgen INC. | $261.84 | 2023-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $253.50 | 2023-2025 | Nemluvio, Aklief |
| Dermavant Sciences, INC. | $231.03 | 2022-2024 | Vtama |
| Abbvie INC. | $222.97 | 2024-2025 | |
| Genzyme Corporation | $205.37 | 2022-2025 | |
| Organon LLC | $147.41 | 2025 | Vtama |
| Lilly USA, LLC | $116.16 | 2023 | Taltz |
| Novartis Pharmaceuticals Corporation | $86.53 | 2025 | |
| Paratek Pharmaceuticals, INC. | $81.89 | 2024 | Nuzyra |
| Leo Pharma INC. | $63.20 | 2024-2025 | Adbry, Anzupgo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $38.35 | 2022-2024 | Cabtreo |
| Ucb, INC. | $31.27 | 2025 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $24.43 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $23.28 | 2024 | Sotyktu |
| Almirall LLC | $21.90 | 2022 | |
| Verrica Pharmaceuticals INC. | $20.21 | 2024 | Ycanth |
| Epi Health, LLC | $17.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.